Video Upload Options

References

1. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptácek LJ.Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome.J Biol Chem. 2003 Dec 19;278(51):51779-85.
2. Casini S, Postma AV. Decreased inward rectification of Kir2.1 channels is anovel mechanism underlying the short QT syndrome. Cardiovasc Res. 2012 Mar15;93(4):535-6. doi: 10.1093/cvr/cvs084.
3. Chun TU, Epstein MR, Dick M 2nd, Andelfinger G, Ballester L, Vanoye CG, GeorgeAL Jr, Benson DW. Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm. 2004 Jul;1(2):235-41.
4. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T,Escolar DM, Fu YH, Ptácek LJ. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003 Jun 10;60(11):1811-6.
5. Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M, Kimura T. A novel gain-of-function KCNJ2mutation associated with short-QT syndrome impairs inward rectification of Kir2.1currents. Cardiovasc Res. 2012 Mar 15;93(4):666-73. doi: 10.1093/cvr/cvr329.
6. Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S,Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y,Zang WJ, Ito M, Matsuura H, Horie M. Phenotype variability in patients carryingKCNJ2 mutations. Circ Cardiovasc Genet. 2012 Jun;5(3):344-53. doi:10.1161/CIRCGENETICS.111.962316.
7. Nguyen HL, Pieper GH, Wilders R. Andersen-Tawil syndrome: clinical andmolecular aspects. Int J Cardiol. 2013 Dec 5;170(1):1-16. Review.
8. Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, Tsunoda A,Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr,Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH,Ptácek LJ. Mutations in Kir2.1 cause the developmental and episodic electricalphenotypes of Andersen's syndrome. Cell. 2001 May 18;105(4):511-9.
9. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A,Napolitano C, Anumonwo J, di Barletta MR, Gudapakkam S, Bosi G, Stramba-BadialeM, Jalife J. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res. 2005 Apr 15;96(7):800-7.
10. Schulze-Bahr E. Short QT syndrome or Andersen syndrome: Yin and Yang of Kir2.1channel dysfunction. Circ Res. 2005 Apr 15;96(7):703-4.
11. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A,Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R.Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest. 2002 Aug;110(3):381-8.
12. Veerapandiyan A, Statland JM, Tawil R. Andersen-Tawil Syndrome. 2004 Nov 22[updated 2018 Jun 7]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH,Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): Universityof Washington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1264/